Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

86.77
+0.59000.68%
Post-market: 86.770.00000.00%16:15 EDT
Volume:2.27M
Turnover:196.55M
Market Cap:50.03B
PE:50.47
High:87.27
Open:86.00
Low:85.00
Close:86.18
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.85
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.71
PE(LYR):47.34

Loading ...

Edwards Lifesciences Price Target Maintained With a $100.00/Share by RBC Capital

Dow Jones
·
Jun 16

Leerink ‘incrementally positive’ on Edwards Lifesciences after TAVR NCD proposal

TIPRANKS
·
Jun 16

RBC Capital Sticks to Its Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
Jun 16

Edwards Lifesciences Buy Rating Reaffirmed as Favorable TAVR Policy Update Supports Growth and $100 Price Target Maintained

TIPRANKS
·
Jun 16

Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Xencor (XNCR) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Jun 16

Edwards Lifesciences Corp. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Edwards Lifesciences (EW)

TIPRANKS
·
Jun 12

Edwards Lifesciences Set to Benefit from TAVR Coverage Update, RBC Says

MT Newswires Live
·
Jun 11

Edwards Lifesciences’ HPI Care Trial Posts Results, Offering Fresh Signals for Predictive Monitoring Investors

TIPRANKS
·
Jun 11

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 10

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Nurix Therapeutics (NRIX) and Gilead Sciences (GILD)

TIPRANKS
·
Jun 09

Analyst Initiates Buy on Edwards Lifesciences, Citing Favorable TAVR Reimbursement Outlook and Expanded Patient Access Potential

TIPRANKS
·
Jun 09

5 Healthcare Stocks That Are Poised To Ride AI to Gains -- Barrons.com

Dow Jones
·
Jun 07

Healthcare Stocks Can Benefit From AI, Too. But That Isn't the Reason to Buy Them. -- Barrons.com

Dow Jones
·
Jun 05

Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Envista names Coree Thomas chief accounting officer, effective Aug. 6

Reuters
·
Jun 04

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 04

Movement Alert|Edwards Lifesciences Falls 4.14% in After-Hours Trading, Trading at $87.7

Market Focus
·
Jun 03

Edwards Lifesciences Corp : TD Cowen Raises Target Price to $104 From $97

THOMSON REUTERS
·
Jun 02

TD Cowen Adjusts Price Target on Edwards Lifesciences to $104 From $97, Maintains Buy Rating

MT Newswires Live
·
Jun 02